Literature DB >> 19626196

Retinal vascular occlusions: an interdisciplinary challenge.

Alireza Mirshahi1, Nicolas Feltgen, Lutz L Hansen, Lars-Olof Hattenbach.   

Abstract

INTRODUCTION: Retinal venous and arterial occlusions are common causes of visual loss. Depending on the location and extent, symptoms may vary from very discrete impairments to complete loss of sight.
METHODS: Selective literature review including the authors' own research data with a particular focus on interdisciplinary aspects.
RESULTS: Retinal vascular occlusions are not a uniform entity. Rather, they reflect the whole breadth of vascular disease. In arterial occlusion, embolic phenomena and Horton's arteritis should be excluded, in addition to local ophthalmological investigations. In retinal venous occlusion, optimal treatment of arterial hypertension is universally useful, while investigations for thrombophilia are useful in patients under 50 years of age. The results of intravitreal injection of corticosteroids and vascular endothelial growth factor inhibitors appear encouraging in treatment of macular edema secondary to retinal vein occlusion. DISCUSSION: While local diagnostic and therapeutic measures are performed by ophthalmologists, there is an important role for interdisciplinary cooperation in the investigation and systemic treatment of these events.

Entities:  

Keywords:  arterial occlusion; ophthalmology; retinal vascular occlusion; venous occlusion; visual impairment

Year:  2008        PMID: 19626196      PMCID: PMC2696914          DOI: 10.3238/arztebl.2008.0474

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  28 in total

1.  Aggressive systematic treatment for central retinal artery occlusion.

Authors:  S Rumelt; Y Dorenboim; U Rehany
Journal:  Am J Ophthalmol       Date:  1999-12       Impact factor: 5.258

2.  A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution.

Authors:  L L Hansen; J Wiek; M Wiederholt
Journal:  Br J Ophthalmol       Date:  1989-11       Impact factor: 4.638

3.  Central retinal artery occlusion: visual outcome.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

4.  Central retinal vein occlusion in patients treated with long-term warfarin sodium (Coumadin) for anticoagulation.

Authors:  Prithvi Mruthyunjaya; William J Wirostko; Ravindra Chandrashekhar; Sandra Stinnett; James C Lai; Vincent Deramo; Johnny Tang; Sundeep Dev; Eric A Postel; Thomas B Connor; Sharon Fekrat
Journal:  Retina       Date:  2006-03       Impact factor: 4.256

Review 5.  Prevalent misconceptions about acute retinal vascular occlusive disorders.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2005-07       Impact factor: 21.198

6.  Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; A Chang
Journal:  Arch Ophthalmol       Date:  1996-10

7.  Transthoracic echocardiographic findings in patients with acute retinal arterial obstruction. A retrospective review. Retinal Emboli of Cardiac Origin Group.

Authors:  S Sharma; A Naqvi; S M Sharma; A F Cruess; G C Brown
Journal:  Arch Ophthalmol       Date:  1996-10

8.  Streptokinase in central retinal vein occlusion: a controlled clinical trial.

Authors:  E M Kohner; J E Pettit; A M Hamilton; C J Bulpitt; C T Dollery
Journal:  Br Med J       Date:  1976-03-06

Review 9.  [Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment].

Authors:  T Ness; C Auw-Hädrich; D Schmidt
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

10.  A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation.

Authors:  L L Hansen; P Danisevskis; H R Arntz; G Hövener; M Wiederholt
Journal:  Br J Ophthalmol       Date:  1985-02       Impact factor: 4.638

View more
  9 in total

Review 1.  [Cardiovascular and hemostaseological view of retinal vascular occlusions].

Authors:  H Seidel; E Stegemann; C Heiss
Journal:  Ophthalmologe       Date:  2014-01       Impact factor: 1.059

2.  [Ophthalmologic diagnostic procedures and imaging of retinal vein occlusions].

Authors:  A Mirshahi; K Lorenz; C Kramann; B Stoffelns; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2011-02       Impact factor: 1.059

3.  [Retrospective case analysis of ophthalmological and systemic risk factors in patients with retinal vascular occlusion].

Authors:  C Klatt; K Purtskhvanidze; H Hasselbach; F Treumer; J Hillenkamp; J Roider
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

4.  [Asymmetric dimethylarginine (ADMA) in retinal vein occlusion-Results from the Gutenberg RVO study].

Authors:  Ann K Rosner; Ellen I Closs; Alice Habermeier; Adrian Gericke; Harald Binder; Inge Scharrer; Norbert Pfeiffer; Katharina A Ponto
Journal:  Ophthalmologe       Date:  2020-09-17       Impact factor: 1.059

5.  Associations Between Retinal Artery/Vein Occlusions and Risk of Vascular Dementia.

Authors:  Cecilia S Lee; Michael L Lee; Laura E Gibbons; Ryan T Yanagihara; Marian Blazes; Jason P Kam; Susan M McCurry; James D Bowen; Wayne C McCormick; Aaron Y Lee; Eric B Larson; Paul K Crane
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Nampt/PBEF/visfatin serum levels: a new biomarker for retinal blood vessel occlusions.

Authors:  Simon Kaja; Anna A Shah; Shamim A Haji; Krishna B Patel; Yuliya Naumchuk; Alexander Zabaneh; Bryan C Gerdes; Nancy Kunjukunju; Nelson R Sabates; Michael A Cassell; Ron K Lord; Kevin P Pikey; Abraham Poulose; Peter Koulen
Journal:  Clin Ophthalmol       Date:  2015-04-07

7.  Evaluation of Ophthalmic Artery Branch Retrograde Intervention in the Treatment of Central Retinal Artery Occlusion (CRAO).

Authors:  Runsheng Wang; Lu Qian; Yi Wang; Yi Zheng; Shanshuang Du; Tao Lei; Peilin Lv; Tan Long; Wenjun Wang
Journal:  Med Sci Monit       Date:  2017-01-08

8.  The Use of Vitamins and Coenzyme Q10 for the Treatment of Vascular Occlusion Diseases Affecting the Retina.

Authors:  Beatriz Fernández-Vega; Javier Nicieza; Ana Álvarez-Barrios; Lydia Álvarez; Montserrat García; Carlos Fernández-Vega; José A Vega; Héctor González-Iglesias
Journal:  Nutrients       Date:  2020-03-09       Impact factor: 5.717

9.  [Retinal arteriovenous vascular occlusion after COVID vaccination with Vaxzevria® (AstraZeneca)-A complication of vaccination or not?]

Authors:  S Groselli; K Gabka; L Bechstein; M Ulbig
Journal:  Ophthalmologe       Date:  2022-03-11       Impact factor: 1.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.